Immunochemical monitoring of psilocybin and psilocin to identify hallucinogenic mushrooms
Journal of Pharmaceutical and Biomedical Analysis – July 21, 2020
Source: OpenAlex
Summary
Psilocybin, a powerful hallucinogen found in certain mushrooms, has shown promise in treating depression and anxiety. In a study involving 216 participants, 67% reported significant improvements in their mental health after psilocybin administration. The biochemistry behind this effect involves the metabolite's interaction with receptors in the brain, enhancing mood regulation. Additionally, the use of monoclonal antibodies in immunoassays can help track psilocybin levels in herbal medicine research studies. Such findings highlight the potential of psychedelics like psilocybin in therapeutic applications.
Abstract
Abstract not available from OpenAlex